Ronald Plasterk

Ronald Plasterk

Company: CureVac

Job title: Senior Vice President Science and Innovation


Examining Second Generation Cancer Vaccines 12:00 pm

Understanding how the bulk of neoantigens within the exome are SNPs, mostly resulting in single amino acid changes, necessitating the selection of neoantigens predicted to be immunogenic Evaluating how current technology allows fast Whole Genome Sequencing, deep long-read sequencing of intact complete mRNAs, and the bioinformatics capacity to handle this information Examining how using this…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.